Xarelto and Maculopathy - a phase IV clinical study of FDA data

Summary:

Maculopathy is reported as a side effect among people who take Xarelto (rivaroxaban), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Elmiron, and have Thrombosis.

The phase IV clinical study analyzes which people have Maculopathy when taking Xarelto. It is created by eHealthMe based on reports of 210,230 people who have side effects when taking Xarelto from the FDA, and is updated regularly.

What is Xarelto?

Xarelto has active ingredients of rivaroxaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 212,378 Xarelto users. Check the latest studies of Xarelto.

What is Maculopathy?

Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest) is found to be associated with 377 drugs and 732 conditions by eHealthMe. Check the latest studies of Maculopathy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

210,230 people reported to have side effects when taking Xarelto.
Among them, 24 people (0.01%) have Maculopathy.

Among these 24 people:

How long have people been on Xarelto when they have Maculopathy? *

What is the gender of people who have Maculopathy when taking Xarelto? *

female: 78.26 %
male: 21.74 %

What is the age of people who have Maculopathy when taking Xarelto? *

What are other drugs people take besides Xarelto? *

Vancomycin: 5 people, 20.83%
Elmiron: 5 people, 20.83%
Xeljanz Xr: 3 people, 12.50%
Vitamin D: 3 people, 12.50%
Hydrocodone Bitartrate And Acetaminophen: 3 people, 12.50%
Losartan: 2 people, 8.33%
Fentanyl: 2 people, 8.33%
Coreg: 2 people, 8.33%
Rivaroxaban: 2 people, 8.33%
Lucentis: 2 people, 8.33%

What are other side effects people have besides Maculopathy? *

Retinal Vessel Occlusion (a blockage in one of the small arteries): 8 people, 33.33%
Retinal Ischaemia (lack of blood supply to retina): 8 people, 33.33%
Retinal Haemorrhage (bleeding from retina): 8 people, 33.33%
Corneal Opacity (scarring or clouding of the cornea): 6 people, 25.00%
Retinal Disorder (disease of retina): 4 people, 16.67%
Road Traffic Accident: 3 people, 12.50%
Heart Attack: 3 people, 12.50%
Loss Of Consciousness: 3 people, 12.50%
Cardiac Disorder: 3 people, 12.50%
Mobility Decreased (ability to move is reduced): 3 people, 12.50%

What are the existing conditions these people have? *

Thrombosis (formation of a blood clot inside a blood vessel): 10 people, 41.67%
Endophthalmitis (inflammation of the internal coats of the eye): 8 people, 33.33%
Blindness: 5 people, 20.83%
Pain: 5 people, 20.83%
Cystitis Interstitial (unknown cause characterized by bladder pain): 5 people, 20.83%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 16.67%
Depression: 3 people, 12.50%
Neuropathy Peripheral (surface nerve damage): 3 people, 12.50%
High Blood Pressure: 3 people, 12.50%
High Blood Cholesterol: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Xarelto and have Maculopathy?

- Check whether Maculopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xarelto:

Xarelto (212,378 reports)

Maculopathy treatments and more:

Maculopathy (5,625 reports)

Browse all side effects of Xarelto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Maculopathy:

Maculopathy (377 drugs)

Browse all the conditions that are associated with Maculopathy:

Maculopathy (732 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rivaroxaban (the active ingredients of Xarelto) and Xarelto (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.